Global Cancer Diagnostics Market Bwc19374
SPECIAL OFFER : 25% Super Discount For All !
Global Cancer Diagnostics Market, By Type (Endometrial Cancer, Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Kidney Cancer, Leukemia, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma), By Application (Imaging, Tumor Biomarkers Tests, Biopsy, Immunohistochemistry, Liquid Biopsy, In Situ Hybridization), By End-User (Hospitals, Imaging Centers, Diagnostic Laboratories, Cancer Research Institutes. and Documentation System), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: November 2021
- Report ID: BWC19374
- Available Format: PDF
- Page: 194
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Research Methodology
- Qualitative Research
- Primary and Secondary Sources
- Quantitative Research
- Primary and Secondary Sources
- Breakdown of Primary Research Respondents
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Industry Participants
- Key Questionnaire asked during Primary Interviews
- Key Primary Responses
- Market Size Estimation
- Assumption for the Study
- Market Breakdown & Data Triangulation
- Qualitative Research
- Executive Summary
- Global Cancer Diagnostics Market – Industry Insights
- DROC Analysis
- Growth Drivers
- Restraints
- Opportunity
- Challenges
- Recent Developments / Technical Landscape
- Regulatory Framework
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Strategic Outlook
- DROC Analysis
- Global Cancer Diagnostics Market Overview
- Market Estimates & Forecast by Value, 2017-2027
- By Value (USD Million)
- By Volume (Thousand Units)
- Market Share & Forecast
- By Type
- Endometrial Cancer
- Bladder Cancer
- Breast Cancer
- Colon and Rectal Cancer
- Kidney Cancer
- Leukemia
- Pancreatic Cancer
- Prostate Cancer
- Thyroid Cancer
- Liver-Lung Cancer
- Melanoma
- Non-Hodgkin Lymphoma
- By Application
- Imaging
- Tumor Biomarkers Tests
- Biopsy
- Immunohistochemistry
- Liquid Biopsy
- In Situ Hybridization
- By End-User
- Hospitals
- Imaging Centers
- Diagnostic Laboratories
- Cancer Research Institutes. and Documentation System
- By Region
- North America
- Europe
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle-East & Africa (MEA)
- By Type
- Market Estimates & Forecast by Value, 2017-2027
- North America Cancer Diagnostics Market Overview
- Market Size and Forecast
- By Value (USD Million), 2017-2027
- Market Share and Forecast
- By Type
- By Application
- By End-User
- By Country
- U.S.
- Canada
- Market Size and Forecast
- Europe Cancer Diagnostics Market Overview
- Market Size and Forecast
- By Value (USD Million), 2017-2027
- Market Share and Forecast
- By Type
- By Application
- By End-User
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Market Size and Forecast
- APAC Cancer Diagnostics Market Overview
- Market Size and Forecast
- By Value (USD Million), 2017-2027
- Market Share and Forecast
- By Type
- By Application
- By End-User
- By Country
- China
- India
- Japan
- South Korea
- Rest of APAC
- Market Size and Forecast
- LATAM Cancer Diagnostics Market Overview
- Market Size and Forecast
- By Value (USD Million), 2017-2027
- Market Share and Forecast
- By Type
- By Application
- By End-User
- By Country
- Mexico
- Brazil
- Rest of LATAM
- Market Size and Forecast
- MEA Cancer Diagnostics Market Overview
- Market Size and Forecast
- By Value (USD Million), 2017-2027
- Market Share and Forecast
- By Type
- By Application
- By End-User
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Europe
- Market Size and Forecast
- Competitive Landscape
-
- List of Key Producers and Their Offerings
- Market Share / Ranking Analysis (2020)
- Competitive Benchmarking, By Operating Parameters
-
- COVID-19 Impact
- Future Impact
- Key Developments during COVID-19
- Impact on Market
- Different Scenario
- Impact on Companies
- Regional Impact
- Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
- GE Healthcare
- Hologic, Inc.
- Janssen Diagnostics, LLC
- Myriad Genetics, Inc.
- Qiagen N.V.
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- AB SCIEX
- Agilent Technologies Inc.
- Abbott Laboratories
- Becton, Dickinson and Company (BD)
- Biocartis SA
- Biocare Medical, LLC
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Cancer Genetics, Inc.
- Danaher Corporation
- Other Prominent Players
- Key Strategic Recommendations
* Financial information of non-listed Companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.
List of Figures
Fig: Global Cancer Diagnostics Segmentation
Fig: Global Cancer Diagnostics Market Value Chain Analysis,
Fig: Company Market Share Analysis, 2020
Fig: Global Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Global Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027
Fig: Global Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027
Fig: Global Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Global Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: North America Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: North America Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027
Fig: North America Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027
Fig: North America Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: North America Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Europe Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Europe Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027
Fig: Europe Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027
Fig: Europe Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Europe Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: the Asia-Pacific Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027
Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027
Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Latin America Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Latin America Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027
Fig: Latin America Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027
Fig: Latin America Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Latin America Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Middle East & Africa Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027
Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027
Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Region, By Value, 2017-2027
List of Tables
Table: Global Cancer Diagnostics Market Size, By Type, By Value, 2017-2027
Table: Global Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027
Table: Global Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: Global Cancer Diagnostics Market Size, By Region, By Value (USD Million), 2017-2027
Table: North America Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027
Table: North America Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027
Table: North America Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: North America Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: Europe Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027
Table: Europe Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027
Table: Europe Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: Europe Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: Latin America Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027
Table: Latin America Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027
Table: Latin America Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: Latin America Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: Hologic, Inc. Financial Analysis
Table: Hologic, Inc. Business Overview
Table: GE Healthcare Financial Analysis
Table: GE Healthcare Business Overview
Table: Janssen Diagnostics LLC Financial Analysis
Table: Janssen Diagnostics LLC Business Overview
Table: Myriad Genetics, Inc. Limited Financial Analysis
Table: Myriad Genetics, Inc. Limited Business Overview
Table: Qiagen N.V. Financial Analysis
Table: Qiagen N.V. Business Overview
Table: Roche Diagnostics Financial Analysis
Table: Roche Diagnostics Business Overview
Table: Siemens Healthineers Financial Analysis
Table: Siemens Healthineers Business Overview
Table: Sysmex Corporation Financial Analysis
Table: Sysmex Corporation Business Overview
Table: Thermo Fisher Scientific, Inc. Financial Analysis
Table: Thermo Fisher Scientific, Inc. Business Overview
Table: AB SCIEX Financial Analysis
Table: AB SCIEX Business Overview
Table: Agilent Technologies Inc. Financial Analysis
Table: Agilent Technologies Inc. Business Overview
Table: Abbott Laboratories Corporation Financial Analysis
Table: Abbott Laboratories Corporation Business Overview
Table: Becton, Dickinson, and Company (BD) Financial Analysis
Table: Becton, Dickinson, and Company (BD) Business Overview
Table: Biocartis SA Financial Analysis
Table: Biocartis SA Business Overview
Table: Biocare Medical, LLC Financial Analysis
Table: Biocare Medical, LLC Business Overview
Table: bioMérieux SA Financial Analysis
Table: bioMérieux SA Business Overview
Table: Bio-Rad Laboratories, Inc. Financial Analysis
Table: Bio-Rad Laboratories, Inc. Business Overview
Table: Cancer Genetics, Inc. Financial Analysis
Table: Cancer Genetics, Inc. Business Overview
Table: Danaher Corporation Financial Analysis
Table: Danaher Corporation Business Overview
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Coustom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.